Sarcopenia.
Journal
Lancet (London, England)
ISSN: 1474-547X
Titre abrégé: Lancet
Pays: England
ID NLM: 2985213R
Informations de publication
Date de publication:
29 Jun 2019
29 Jun 2019
Historique:
received:
10
01
2019
revised:
13
04
2019
accepted:
25
04
2019
pubmed:
7
6
2019
medline:
25
7
2019
entrez:
8
6
2019
Statut:
ppublish
Résumé
Sarcopenia is a progressive and generalised skeletal muscle disorder involving the accelerated loss of muscle mass and function that is associated with increased adverse outcomes including falls, functional decline, frailty, and mortality. It occurs commonly as an age-related process in older people, influenced not only by contemporaneous risk factors, but also by genetic and lifestyle factors operating across the life course. It can also occur in mid-life in association with a range of conditions. Sarcopenia has become the focus of intense research aiming to translate current knowledge about its pathophysiology into improved diagnosis and treatment, with particular interest in the development of biomarkers, nutritional interventions, and drugs to augment the beneficial effects of resistance exercise. Designing effective preventive strategies that people can apply during their lifetime is of primary concern. Diagnosis, treatment, and prevention of sarcopenia is likely to become part of routine clinical practice.
Identifiants
pubmed: 31171417
pii: S0140-6736(19)31138-9
doi: 10.1016/S0140-6736(19)31138-9
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
2636-2646Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.